Pharmaceutical

Sanofi and Orano Med link for radioligand therapy development

Sanofi and Orano Group subsidiary Orano Med have announced a partnership to enhance the development of next-generation RLTs.

Oct 20, 2024 - 04:00
Sanofi and Orano Med link for radioligand therapy development
Sanofi and Orano Group subsidiary Orano Med have announced a partnership to enhance the development of next-generation RLTs.
Read the original article

Tags:

Previous Article

Unresolved clawback issues obstruct Greece’s potential pharmaceutical framework ...

Next Article

Opioid addiction market to reach $2.4 billion across 8MM by 2033

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Moderna cuts five programmes to save $1.1bn in R&D costs

Moderna cuts five programmes to save $1.1bn in R&D costs

Sep 14, 2024

Filings signal: Despite Covid losses, pharma earnings are promising

Filings signal: Despite Covid losses, pharma earnings a...

Aug 2, 2023

New Biden initiative targets controversial hospital ‘facility fees’ that often surprise patients

New Biden initiative targets controversial hospital ‘fa...

Jul 8, 2023